PPT-Management of Type II Diabetes in Patients with Kidney Transplantation
Author : adia | Published Date : 2022-02-12
Brendan Peterson Objectives Review background information Determine special considerations for pharmacotherapy in T2DM kidney transplant patients Summarize evidencebased
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Management of Type II Diabetes in Patien..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Management of Type II Diabetes in Patients with Kidney Transplantation: Transcript
Brendan Peterson Objectives Review background information Determine special considerations for pharmacotherapy in T2DM kidney transplant patients Summarize evidencebased treatment recommendations. Arch Enemies!. Dr. Kenneth Thomas, MD. Diabetes Support Group. Starkville, MS. 7/10/12. Introduction. 25.8 million children and adults in the United States—8.3% of the population—have diabetes. 10.9 million, or 26.9% of all people in . Outline. Basics of transplantation. Benefits of transplantation. Immunosuppressive medications. Common post-transplant problems. Basics of Transplantation. Kidney transplantation is the most effective therapy for end-stage renal disease.. 1. AACE Comprehensive Diabetes Care: Glucose Goals . Parameter. Treatment Goal for . Nonpregnant. Adults. A1C (%). . Individualize based on age, comorbidities, and duration of disease*. ≤6.5 for most. Juan Carlos Caicedo, MD FACS. Di. rector, Hispanic Transplant Program. Adult transplant Surgeon (NMH). Pediatric Transplant Surgeon (LCH). Overview. Introduction . Kidney ( Living / deceased/ combined stem cell). 1. History . Since early times the idea of tissue and organ transplantation has captured the imagination of successive generations. Early attempts at organ transplantation were ended with failure due to . Jessica Wen, M.D.. The Children’s Hospital of Philadelphia. Nov. 3, 2018. Objectives. P. rimary functions of the liver. I. ndications . for Liver . Transplant. P. rocess of liver transplant evaluation and listing. Introduction. Kidney transplantation (KT) is the best renal replacement therapy for many patients with End Stage Kidney Disease (ESKD) . Knowledge about KT helps patients make more informed treatment decisions. Prof Paul A . Corris. Newcastle University. Newcastle Upon Tyne. Pulmonary Hypertension. Which of the following statements are true. A breathless patient with normal LV systolic function and whose RHC results show a mean PAP of 30 mmHg and a PCW of 23 mmHg has pulmonary arterial hypertension. Cardiac : Eligibility and Listing Criteria in Canada 2012 1 Cardiac Transplantation: Eligibility and Listing Criteria in Canada Debra Isaac MD, Michael Chan MD, Haissam Haddad MD, Anson Cheung MD, Type II and Pre Diabetes Eat Right 4 Your Type | Featuring brandnew targeted food and supplement lists specific to diabetes that readers wont find anywhere elseAmericas fastestgrowing health problem just got dealt a major blow Dr Peter J DAdamo the creator of the Blood Type Diet which has forever c Tracy Anderson-Haag, . PharmD. , BCPS. Clinical Pharmacy Specialist. Hennepin Healthcare. and. Clinical Assistant Professor. University of Minnesota, College of Pharmacy. Objectives. Describe recent changes to medication labeling, guidelines and practice patterns for use of controversial medications in patients with chronic kidney disease. for HCSWs. Katharine Ramage. Diabetes MCN Professional Education Lead/DSN. Learning Outcomes. Develop an understanding of the different types of diabetes, risk factors for developing diabetes, how it can present and how it is diagnosed. Download PDF The Kidney Stone Removal Report™ eBook by Joe Barton a comprehensive guide for treating kidney stone conditions naturally. Dr Jean . Filipov. , PhD. UH . Alexandrovska. Sofia, Bulgaria. Plan of the presentation. Biochemical abnormalities after kidney transplantation (KT). Bone disease after KT. Vascular involvement after KT.
Download Document
Here is the link to download the presentation.
"Management of Type II Diabetes in Patients with Kidney Transplantation"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents